Atlas FDA

T-SPOT .TB TEST

FDA premarket approval P070006/S008 · decided 2012-09-05

Approval details

PMA number
P070006
Supplement
S008
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
T-SPOT .TB TEST
Generic name
Mycobacterium tuberculosis, Cell mediated immune response, enzyme-linked immunospot test
Applicant
Oxford Immunotec, Ltd.
Date received
2012-08-27
Decision date
2012-09-05
Days to decision
9 days
Decision code
APPR
Product code
OJN
Advisory committee
Microbiology
Expedited review
No
Location
Milton Park, Abingdon Oxfordshire
Statement
APPROVAL FOR A DESIGN CHANGE, FOR A LARGER REAGENT VOLUME FORMAT FORTHE T-CELL XTEND REAGENT, AN ACCESSORY TO THE T-SPOT TB TEST, TO INCREASE THE VOLUME FROM 3 X 2ML VIALS IN A PACK TO A 50ML BOTTLE.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.